原发性干燥综合征孕妇不良妊娠结局风险增加
该回顾性研究纳入中国安徽省多家医院2015年1月至2022年12月就诊的164例原发性干燥综合征(pSS)孕妇和328例对照,发现pSS组自然流产(12.80% vs 1.52%,p<0.001)、治疗性流产(6.10% vs 0.91%,p<0.05)、胎盘异常(14.63% vs 6.40%,p<0.05)及活产新生儿先天性心脏异常(27.34% vs 12.03%,p<0.05)比例均高于对照组;在pSS妊娠中,低分子肝素(LMWH)应用是胎儿存活的独立保护因素。
要点
- pSS孕妇自然流产(12.80% vs 1.52%,p<0.001)和治疗性流产(6.10% vs 0.91%,p<0.05)比例高于对照。
- pSS组产前超声胎盘异常比例高于对照(14.63% vs 6.40%,p<0.05)。
- pSS组活产新生儿先天性心脏异常比例高于对照(27.34% vs 12.03%,p<0.05)。
核心结论
- 与非自身免疫对照组相比,pSS女性妊娠面临更多挑战;低分子肝素抗凝治疗是胎儿存活的独立保护措施。
研究设计与样本
- 回顾性分析中国安徽省多家医院2015年1月至2022年12月接受门诊或住院诊疗的pSS孕妇,纳入164例pSS孕妇和328例对照。
主要发现
- pSS组自然流产比例为12.80%,对照组为1.52%(p<0.001)。
- pSS组治疗性流产比例为6.10%,对照组为0.91%(p<0.05)。
- pSS组产前超声检出胎盘异常比例为14.63%,对照组为6.40%(p<0.05)。
- pSS组活产新生儿先天性心脏异常发生率为27.34%,对照组为12.03%(p<0.05)。
- pSS妊娠中胎儿存活组预防性抗凝治疗使用多于胎儿丢失组,低分子肝素应用为胎儿存活的独立保护因素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: This study aimed to identify risk factors contributing to diverse pregnancy outcomes in primary Sjögren's syndrome (pSS) cases. METHODS: A retrospective analysis was conducted on pregnant individuals with pSS, who received outpatient or inpatient care across multiple hospitals in Anhui Province, China, from January 2015 to December 2022. RESULTS: This study included 164 pregnant women with pSS and 328 control subjects, with no statistically significant difference in average age between the two groups. Analysis of pregnancy outcomes revealed that, compared with the control group, pregnant women in the pSS group were more likely to experience miscarriages, both spontaneous (12.80% vs 1.52%, p<0.001) and therapeutic (6.10% vs 0.91%, p<0.05). The proportion of placental abnormalities detected during prenatal ultrasound in women from the pSS group was higher (14.63% vs 6.40%, p<0.05). In the analysis of pregnancy outcomes for live-born neonates, a higher incidence of congenital heart abnormalities was observed in the pSS group (27.34% vs 12.03%, p<0.05). While there were no significant differences between the pSS pregnancies in terms of both normal and adverse pregnancy outcomes, a comparison of fetal survival and fetal loss in pSS pregnancies revealed a greater use of prophylactic anticoagulant therapy in the fetal survival group. Notably, the application of low molecular weight heparin (LMWH) emerged as an independent protective factor for fetal survival. CONCLUSIONS: Compared with non-autoimmune controls, pregnancy in women with pSS presents more challenges. Importantly, we observed that the use of LMWH as anticoagulant therapy is an independent protective measure for fetal survival.
引用
- Tan Z, Shao M, Zhou Y, et al. Increased risk of adverse gestational outcomes in pregnant women with primary Sjögren's syndrome. RMD Open. 2024. PMID: 38806189. doi:10.1136/rmdopen-2023-003616
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。